| Literature DB >> 29148294 |
Xianrui Xie1, Wei Cong1, Feng Zhao1, Hongjuan Li1, Wenyu Xin1, Guige Hou1, Chunhua Wang1.
Abstract
Twenty-four novel 5-phenyl-1,3,4-oxadiazole-2-thiol (POT) analogues, benzo[d]oxazole-2-thiol, benzo[d]thiazole-2-thiol and 5-methyl-1,3,4-thiadiazole-2-thiol-substituted N,N-bis(2-hydroxyethyl) quaternary ammonium salts (QAS) (5a-d, 6a-d, 7a-d, 10a-d, 13a-d, 16a-d) were prepared and characterised by FTIR, NMR and elemental analysis. Part of target compounds (5d, 6d, 7d, 10d, 13d, 16d) displayed potent antimicrobial effect against ten common pathogens (S. aureus, α-H-tococcus, β-H-tococcus, E. coli, P. aeruginosa, Proteus vulgaris, Canidia Albicans, Cytospora mandshurica, Physalospora piricola, Aspergillus niger) and had relatively low cytotoxity against two human cell lines (HaCat and LO2). TEM and SEM images of E. coli and S. aureus morphologies treated with 7d showed that the antibacterial mechanism might be the QAS fixing on cell wall surfaces and puncturing to result in the release of bacterial cytoplasm. This study provides new information of QAS, which could be used to design novel antimicrobial agents applied in clinic or agriculture.Entities:
Keywords: 5-Phenyl-1,3,4-oxadiazole-2-thiol; antibacterial activity; antifungal activity; cytotoxicity; quaternary ammonium salts
Mesh:
Substances:
Year: 2018 PMID: 29148294 PMCID: PMC6010013 DOI: 10.1080/14756366.2017.1396456
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051
Figure 1.Representative target compounds in previous work.
Scheme 1.The synthesis and structures of six series of noval QASs.
Minimal inhibitory concentration (MIC) of QASs (μg/mL).
| Compd | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3.125 | 3.125 | 1.56 | 25 | 25 | 25 | 12.5 | 6.25 | 3.125 | 3.125 | |
| 3.125 | 6.25 | 1.56 | 6.25 | 25 | 12.5 | 12.5 | 6.25 | 1.56 | 3.125 | |
| 6.25 | 6.25 | 6.25 | 25 | 12.5 | 25 | 6.25 | 3.125 | 3.125 | 3.125 | |
| 100 | 50 | 25 | 100 | 100 | 100 | 50 | 50 | 12.5 | 50 | |
| 25 | 12.5 | 12.5 | 25 | 50 | 50 | 25 | 25 | 6.25 | 50 | |
| 25 | 12.5 | 6.25 | 25 | 50 | 50 | 25 | 12.5 | 3.125 | 25 | |
| 12.5 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 12.5 | 3.125 | 25 | |
| 50 | 50 | 25 | 50 | 100 | 100 | 50 | 12.5 | 6.25 | 25 | |
| 25 | 12.5 | 12.5 | 25 | 50 | 50 | 25 | 12.5 | 3.125 | 12.5 | |
| 25 | 12.5 | 6.25 | 25 | 50 | 25 | 25 | 12.5 | 3.125 | 12.5 | |
| 6.25 | 6.25 | 3.125 | 25 | 50 | 25 | 12.5 | 6.25 | 1.56 | 6.25 | |
| 50 | 25 | 12.5 | 50 | 50 | 50 | 25 | 12.5 | 12.5 | 25 | |
| 25 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 6.25 | 3.125 | 12.5 | |
| 12.5 | 12.5 | 3.125 | 25 | 50 | 25 | 6.25 | 6.25 | 1.56 | 6.25 | |
| 6.25 | 6.25 | 1.56 | 12.5 | 25 | 12.5 | 6.25 | 3.125 | 1.56 | 6.25 | |
| 100 | 50 | 25 | 100 | 100 | 100 | 50 | 50 | 25 | 50 | |
| 50 | 25 | 12.5 | 50 | 50 | 50 | 50 | 25 | 12.5 | 25 | |
| 25 | 25 | 6.25 | 50 | 50 | 50 | 25 | 6.25 | 6.25 | 12.5 | |
| 12.5 | 12.5 | 6.25 | 25 | 25 | 25 | 12.5 | 6.25 | 3.125 | 6.25 | |
| 50 | 50 | 12.5 | 50 | 100 | 100 | 25 | 25 | 25 | 25 | |
| 25 | 25 | 12.5 | 50 | 50 | 50 | 25 | 6.25 | 6.25 | 12.5 | |
| 12.5 | 25 | 6.25 | 25 | 25 | 25 | 12.5 | 3.125 | 3.125 | 6.25 | |
| 6.25 | 12.5 | 1.56 | 25 | 25 | 25 | 6.25 | 1.56 | 3.125 | 3.125 | |
| 100 | 50 | 50 | 100 | 200 | 100 | 50 | 50 | 25 | 50 | |
| 50 | 50 | 25 | 50 | 100 | 50 | 25 | 25 | 12.5 | 25 | |
| 25 | 25 | 6.25 | 50 | 50 | 50 | 25 | 12.5 | 12.5 | 12.5 | |
| 12.5 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 12.5 | 6.25 | 12.5 |
Minimal bactericidal concentration (MBC) of QASs (μg/mL).
| Compd | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3.125 | 3.125 | 1.56 | 25 | 25 | 25 | 25 | 6.25 | 3.125 | 6.25 | |
| 6.25 | 6.25 | 3.125 | 12.5 | 25 | 12.5 | 12.5 | 6.25 | 3.125 | 6.25 | |
| 12.5 | 6.25 | 6.25 | 50 | 25 | 50 | 12.5 | 6.25 | 3.125 | 3.125 | |
| 100 | 50 | 25 | 100 | 100 | 100 | 50 | 50 | 12.5 | 50 | |
| 50 | 25 | 12.5 | 50 | 50 | 50 | 25 | 25 | 6.25 | 50 | |
| 25 | 12.5 | 12.5 | 50 | 50 | 50 | 25 | 12.5 | 6.25 | 25 | |
| 12.5 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 12.5 | 3.125 | 25 | |
| 50 | 50 | 25 | 50 | 100 | 100 | 50 | 25 | 12.5 | 25 | |
| 25 | 25 | 12.5 | 50 | 50 | 50 | 25 | 12.5 | 6.25 | 25 | |
| 25 | 12.5 | 6.25 | 25 | 50 | 25 | 25 | 12.5 | 3.125 | 12.5 | |
| 12.5 | 6.25 | 3.125 | 25 | 50 | 25 | 12.5 | 6.25 | 1.56 | 6.25 | |
| 50 | 25 | 12.5 | 50 | 50 | 50 | 25 | 12.5 | 12.5 | 25 | |
| 25 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 12.5 | 3.125 | 12.5 | |
| 12.5 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 6.25 | 3.125 | 12.5 | |
| 6.25 | 6.25 | 1.56 | 12.5 | 25 | 12.5 | 6.25 | 3.125 | 1.56 | 6.25 | |
| 100 | 50 | 25 | 100 | 200 | 100 | 100 | 50 | 25 | 50 | |
| 50 | 50 | 25 | 100 | 100 | 50 | 50 | 25 | 25 | 25 | |
| 25 | 25 | 12.5 | 50 | 50 | 50 | 25 | 12.5 | 6.25 | 12.5 | |
| 12.5 | 12.5 | 6.25 | 25 | 25 | 25 | 12.5 | 6.25 | 6.25 | 12.5 | |
| 50 | 50 | 25 | 100 | 100 | 100 | 50 | 25 | 25 | 25 | |
| 50 | 25 | 12.5 | 50 | 100 | 50 | 25 | 12.5 | 12.5 | 12.5 | |
| 12.5 | 25 | 6.25 | 25 | 50 | 25 | 25 | 6.25 | 3.125 | 6.25 | |
| 6.25 | 12.5 | 3.125 | 25 | 25 | 25 | 6.25 | 6.25 | 3.125 | 6.25 | |
| 200 | 100 | 50 | 200 | 200 | 200 | 50 | 50 | 25 | 50 | |
| 100 | 50 | 25 | 100 | 100 | 50 | 50 | 25 | 25 | 25 | |
| 25 | 25 | 12.5 | 50 | 50 | 50 | 25 | 25 | 12.5 | 25 | |
| 25 | 12.5 | 6.25 | 25 | 50 | 25 | 12.5 | 12.5 | 6.25 | 12.5 |
Cytotoxicity of QASs for HaCat and LO2 cells.
| IC50 (μg/mL) | IC50 (μg/mL) | IC50 (μg/mL) | ||||||
|---|---|---|---|---|---|---|---|---|
| Compd | LO2 | HaCat | Compd | LO2 | HaCat | Compd | LO2 | HaCat |
| 2.12 ± 0.43 | 3.19 ± 0.26 | 2.06 ± 0.06 | 2.54 ± 0.12 | 14.23 ± 2.15 | 18.27 ± 2.21 | |||
| 83.51 ± 5.67 | 76.52 ± 4.58 | 44.26 ± 3.31 | 23.84 ± 2.13 | 64.28 ± 4.12 | 45.06 ± 3.23 | |||
| 46.75 ± 3.32 | 50.83 ± 3.65 | 16.78 ± 1.35 | 9.05 ± 0.92 | 29.58 ± 2.86 | 17.84 ± 1.56 | |||
| 23.86 ± 1.68 | 19.39 ± 1.23 | 12.90 ± 1.37 | 6.94 ± 0.53 | 16.84 ± 1.61 | 10.51 ± 1.02 | |||
| 6.95 ± 0.62 | 6.14 ± 0.53 | 5.08 ± 0.51 | 4.16 ± 0.43 | 8.96 ± 0.46 | 6.02 ± 0.35 | |||
| 74.35 ± 4.12 | 62.57 ± 3.82 | 88.27 ± 5.89 | 54.62 ± 3.16 | >100 | >100 | |||
| 38.72 ± 2.92 | 32.57 ± 2.69 | 42.92 ± 2.37 | 30.38 ± 2.89 | 86.52 ± 5.33 | 65.38 ± 3.12 | |||
| 19.56 ± 1.62 | 12.06 ± 1.57 | 25.32 ± 1.78 | 15.86 ± 1.23 | 43.18 ± 2.67 | 36.87 ± 2.81 | |||
| 5.86 ± 0.61 | 5.25 ± 0.37 | 9.96 ± 0.76 | 7.14 ± 0.51 | 30.12 ± 2.32 | 27.03 ± 2.53 | |||
Haemolysis rate (%) of QASs with different concentration (μg/mL).
| Haemolysis rate (%) | |||||||
|---|---|---|---|---|---|---|---|
| Compd | 6.25 | 12.50 | 25.00 | 50.00 | 100.00 | 200.00 | 400.00 |
| 1.51 ± 0.31 | 1.39 ± 0.38 | 12.69 ± 1.87 | 63.85 ± 4.56 | 92.36 ± 3.78 | 96.28 ± 2.97 | 98.53 ± 1.23 | |
| 0.86 ± 0.28 | 2.51 ± 0.87 | 5.29 ± 1.22 | 37.05 ± 3.78 | 62.18 ± 3.53 | 86.02 ± 3.82 | 95.67 ± 3.54 | |
| 0.18 ± 0.05 | 0.42 ± 0.13 | 0.93 ± 0.41 | 4.11 ± 0.89 | 17.07 ± 2.34 | 82.75 ± 3.18 | 90.61 ± 4.23 | |
| 0.21 ± 0.03 | 0.53 ± 0.15 | 1.37 ± 0.87 | 1.54 ± 0.96 | 3.25 ± 1.23 | 6.21 ± 3.21 | 35.64 ± 4.87 | |
| 0.29 ± 0.08 | 0.68 ± 0.23 | 1.87 ± 1.35 | 2.19 ± 1.29 | 3.92 ± 1.02 | 21.08 ± 4.55 | 65.49 ± 4.13 | |
| 0.43 ± 0.16 | 0.75 ± 0.19 | 2.31 ± 0.67 | 4.89 ± 0.53 | 33.13 ± 4.87 | 52.28 ± 6.34 | 67.15 ± 5.89 | |
| 0.49 ± 0.12 | 0.87 ± 0.27 | 2.43 ± 0.82 | 4.81 ± 0.74 | 32.41 ± 6.78 | 66.71 ± 5.21 | 66.92 ± 4.12 | |
| 0.15 ± 0.08 | 0.35 ± 0.17 | 0.51 ± 0.19 | 0.99 ± 0.12 | 3.38 ± 1.23 | 7.09 ± 2.89 | 40.96 ± 5.32 | |
| 0.18 ± 0.06 | 0.51 ± 0.08 | 0.43 ± 0.10 | 0.70 ± 0.18 | 4.61 ± 0.31 | 26.16 ± 3.68 | 80.37 ± 4.98 | |
| 0.57 ± 0.15 | 0.42 ± 0.13 | 0.67 ± 0.13 | 3.56 ± 1.32 | 35.76 ± 5.10 | 82.52 ± 6.12 | 89.39 ± 4.35 | |
| 0.64 ± 0.19 | 1.05 ± 0.28 | 2.02 ± 3.45 | 4.85 ± 4.65 | 36.43 ± 6.35 | 85.62 ± 4.86 | 92.46 ± 3.87 | |
| 1.03 ± 0.56 | 2.50 ± 1.08 | 1.01 ± 0.58 | 1.98 ± 0.68 | 5.66 ± 1.23 | 20.76 ± 3.28 | 34.73 ± 4.78 | |
| 1.41 ± 0.43 | 1.48 ± 0.68 | 2.20 ± 0.68 | 2.59 ± 0.89 | 13.84 ± 2.73 | 30.63 ± 3.76 | 85.75 ± 5.67 | |
| 0.18 ± 0.06 | 0.75 ± 0.19 | 1.19 ± 0.76 | 1.92 ± 0.87 | 14.08 ± 0.69 | 38.82 ± 3.12 | 79.03 ± 4.08 | |
| 1.51 ± 0.91 | 1.71 ± 0.12 | 2.32 ± 1.86 | 4.77 ± 1.57 | 12.54 ± 4.79 | 39.62 ± 3.93 | 87.75 ± 3.26 | |
| 0.13 ± 0.06 | 0.40 ± 0.08 | 0.43 ± 0.10 | 0.83 ± 0.43 | 0.31 ± 0.11 | 1.27 ± 0.85 | 1.26 ± 0.82 | |
| 0.17 ± 0.09 | 0.36 ± 0.09 | 0.12 ± 0.05 | 0.09 ± 0.02 | 0.85 ± 0.32 | 1.89 ± 0.72 | 1.52 ± 0.87 | |
| 0.36 ± 0.08 | 1.37 ± 0.18 | 1.75 ± 0.53 | 3.87 ± 1.41 | 1.89 ± 0.67 | 34.67 ± 4.91 | 53.50 ± 6.04 | |
| 1.28 ± 0.87 | 2.36 ± 1.23 | 3.31 ± 1.13 | 6.02 ± 1.11 | 39.95 ± 3.25 | 60.77 ± 4.37 | 74.32 ± 4.98 | |
| 0.24 ± 0.05 | 0.27 ± 0.12 | 0.50 ± 0.12 | 0.81 ± 0.23 | 1.12 ± 0.87 | 1.23 ± 0.92 | 6.27 ± 2.32 | |
| 0.37 ± 0.13 | 0.68 ± 0.37 | 1.03 ± 0.45 | 1.17 ± 0.74 | 4.05 ± 0.68 | 8.66 ± 1.85 | 44.95 ± 3.91 | |
| 0.26 ± 0.05 | 0.70 ± 0.12 | 0.30 ± 0.09 | 1.40 ± 0.73 | 27.70 ± 3.96 | 51.09 ± 3.27 | 73.46 ± 4.76 | |
| 0.56 ± 0.13 | 1.50 ± 0.72 | 3.98 ± 1.03 | 11.18 ± 2.86 | 48.65 ± 3.54 | 65.17 ± 3.91 | 83.68 ± 4.12 | |
| 0.17 ± 0.04 | 0.21 ± 0.10 | 0.35 ± 0.12 | 0.47 ± 0.11 | 0.78 ± 0.17 | 1.23 ± 0.92 | 3.55 ± 1.03 | |
| 0.19 ± 0.03 | 0.32 ± 0.26 | 0.45 ± 0.27 | 0.51 ± 0.76 | 0.80 ± 0.65 | 1.54 ± 0.92 | 4.37 ± 2.19 | |
| 0.23 ± 0.09 | 0.44 ± 0.17 | 0.49 ± 0.21 | 0.58 ± 0.21 | 0.82 ± 0.27 | 1.63 ± 0.98 | 5.45 ± 1.72 | |
| 0.28 ± 0.06 | 0.57 ± 0.22 | 0.73 ± 0.27 | 0.86 ± 0.51 | 1.53 ± 0.87 | 5.94 ± 2.13 | 21.39 ± 3.12 | |
Figure 2.Images of E. coli obtained by SEM (a, c & e; scale bar = 1.0 μm) and TEM (b, d & f; scale bar = 0.1 μm) following treatment with culture medium MHB (control; a & b), compound 7d under the concentration 100 μg/mL for 4 h (c & d), 12 h (e & f).
Figure 3.Images of S. aureus obtained by SEM (a, c & e; scale bar = 1.0 μm) and TEM (b, d & f; scale bar = 0.1 μm) following treatment with culture medium MHB (control; a & b), compound 7d under the concentration 100 μg/mL for 4 h (c & d), 12 h (e & f).